Cancer risk and outcomes program
Cancer Epidemiology Research Program
['FUNDING_P30'] · UNIV OF NORTH CAROLINA CHAPEL HILL · NIH-11469237
This program looks at how genes, environment, and tumor biology affect cancer risk, treatment, and survivorship for people with or at risk for cancers like breast, colon, prostate, lung, and head and neck.
Quick facts
| Phase | ['FUNDING_P30'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIV OF NORTH CAROLINA CHAPEL HILL (nih funded) |
| Locations | 1 site (CHAPEL HILL, UNITED STATES) |
| Trial ID | NIH-11469237 on ClinicalTrials.gov |
What this research studies
From the patient's perspective, the program combines large population studies and disease registries in North Carolina and beyond to learn what raises cancer risk and what affects survival. Researchers link medical records, screening registries, survey data, and stored biological samples to find patterns, biomarkers, and risk groups. The team uses molecular and pathology analyses of tumors and precursor lesions together with statistical and big-data methods. A major focus is identifying and reducing health disparities so results help people in underserved communities.
Who could benefit from this research
Good fit: Ideal candidates would include people with or at risk for breast, colon, prostate, lung, or head and neck cancers, especially those who live in North Carolina or are enrolled in the program's registries or partner studies.
Not a fit: People with cancer types not covered by the program, individuals needing immediate treatment rather than participation in research, or those outside the program's geographic/registry reach may not see direct benefit.
Why it matters
Potential benefit: If successful, this work could lead to better ways to prevent cancer, find it earlier, tailor treatments, and improve long-term survivorship for affected patients.
How similar studies have performed: Previous population-based and biomarker studies have improved screening and risk prediction for some cancers, while integrative molecular epidemiology is a growing approach with promising but still maturing results.
Where this research is happening
CHAPEL HILL, UNITED STATES
- UNIV OF NORTH CAROLINA CHAPEL HILL — CHAPEL HILL, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: HENDERSON, LOUISE — UNIV OF NORTH CAROLINA CHAPEL HILL
- Study coordinator: HENDERSON, LOUISE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Breast Cancer, Cancer Burden, Cancer Cause, Cancer Center Support Grant